FIELD: medical technics. SUBSTANCE: room- temperature stable aqueous composition for patient injection includes biologically-active peptide, e.g. vasopressin, buffer, quaternary ammonium-type preservative or disinfectant and osmotic pressure controlling agent. Composition is buffered to pH between approximately 4 and 6 by buffer preferably consisting of citrate and/or phosphate, whereas preferable preservative or disinfectant benzalkonium chloride. Composition prevents peptides contained therein from sticking to walls of container, especially those of polymer materials. EFFECT: extended choice of biologically-active peptides for nasal administration. 7 cl, 1 dwg, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS FOR NASAL ADMINISTRATION OF DESMOPRESSIN | 1994 |
|
RU2135204C1 |
ADMINISTRATION OF DESMOPRESSIN BY NASAL ROUTE | 1997 |
|
RU2173559C2 |
STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | 1995 |
|
RU2140790C1 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2737264C2 |
HEPTAPEPTIDE OXYTOCIN ANALOGS | 1997 |
|
RU2180668C2 |
OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
SAFE APPLICATION OF DESMOPRESSINUM | 2010 |
|
RU2569756C2 |
ORAL PHARMACEUTICAL COMPOSITION OF DESMOPRESSIN | 2008 |
|
RU2474414C2 |
PEPTIDE COMPOUNDS | 2007 |
|
RU2415149C2 |
Authors
Dates
1999-10-27—Published
1994-06-22—Filed